Newsletters
ePaper
Sign in
Home
India
Assembly Polls 2024
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
News Shots
Explainers
Bengaluru
Science
Trending
Photos
Brandspot
DH Specials
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
Bharat Biotech
Bharat Biotech ties up with Alopexx to develop anti-microbial vaccine
As part of the collaboration, the companies will co-develop and commercialise the vaccine -- AV0328, in India and other licensed territories, Bharat Biotech said in a statement.
11 September 2024, 10:04 IST
Bharat Biotech ties up with Alopexx to develop anti-microbial vaccine
11 September 2024, 10:04 IST
Hyderabad-based Bharat Biotech launches oral cholera vaccine
Currently, only one manufacturer supplies OCVs worldwide, resulting in a yearly deficit of around 40 million doses. To mitigate this global shortage of oral cholera vaccine, Bharat Biotech has established large-scale manufacturing facilities in Hyderabad and Bhubaneswar with a capacity to produce up to 200 million doses.
27 August 2024, 09:01 IST
Hyderabad-based Bharat Biotech launches oral cholera vaccine
27 August 2024, 09:01 IST
Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: Modi government
Initially, when Bharat Biotech filed the patent application, it bore only its name in the application. As soon as the government and ICMR came to know about it, 'we questioned them' as the co-ownership, co-inventor names were not there, Union health minister J P Nadda said.
02 August 2024, 10:39 IST
Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: Modi government
02 August 2024, 10:39 IST
Covaxin developed with single-minded focus on safety first: Bharat Biotech
The vaccine was evaluated in more than 27,000 subjects as part of its licensure process, Bharat Biotech stated.
02 May 2024, 17:04 IST
Covaxin developed with single-minded focus on safety first: Bharat Biotech
02 May 2024, 17:04 IST
Bharat Biotech begins clinical trials of Tuberculosis vaccine on adults in India
The trials are carried out by Bharat Biotech in close collaboration with Biofabri.
24 March 2024, 09:15 IST
Bharat Biotech begins clinical trials of Tuberculosis vaccine on adults in India
24 March 2024, 09:15 IST
Bharat Biotech, University of Sydney ink pact for vaccine research collaboration
Bharat Biotech had played a key role in the combat against Covid-19 with its indigenously developed COVAXIN.
28 November 2023, 10:23 IST
Bharat Biotech, University of Sydney ink pact for vaccine research collaboration
28 November 2023, 10:23 IST
Neglected diseases become tomorrow’s global pandemics, says Bharat Biotech Executive Chairman
Delivering the Foundation Day lecture at CSIR-NIIST here, Dr Ella said it is significant to note that in vaccine national security, India is on par with US and Europe.
06 October 2023, 17:05 IST
Neglected diseases become tomorrow’s global pandemics, says Bharat Biotech Executive Chairman
06 October 2023, 17:05 IST
G20 delegates visit Bharat Biotech's Genome Valley unit
One of the key features of the Genome Valley is the presence of several research and innovation institutions
07 June 2023, 07:19 IST
G20 delegates visit Bharat Biotech's Genome Valley unit
07 June 2023, 07:19 IST
Bharat Biotech's nasal Covid vaccine iNCOVACC launched
'iNCOVACC' is priced at Rs 800 for private markets and at Rs 325 for supplies to the government of India and state governments
26 January 2023, 10:48 IST
Bharat Biotech's nasal Covid vaccine iNCOVACC launched
26 January 2023, 10:48 IST
First Indian intranasal Covid vax to be out on Jan 26
In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government
21 January 2023, 14:37 IST
First Indian intranasal Covid vax to be out on Jan 26
21 January 2023, 14:37 IST
<
1
2
...
44
>